FOLEY & LARDNER LLP

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · pharmaceutical manufacturing

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Jan 19, 2026

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing and issues related to supply chain resilience.

Pharmacy

Issues related to domestic manufacturing and issues related to supply chain resilience.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.